Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice.
Saved in:
| Title: | Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice. |
|---|---|
| Authors: | Edvardsson U; Cell Biology and Biochemistry, Astra Hässle AB, S-431 83 Mölndal, Sweden., Bergström M, Alexandersson M, Bamberg K, Ljung B, Dahllöf B |
| Source: | Journal of lipid research [J Lipid Res] 1999 Jul; Vol. 40 (7), pp. 1177-84. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0376606 Publication Model: Print Cited Medium: Print ISSN: 0022-2275 (Print) Linking ISSN: 00222275 NLM ISO Abbreviation: J Lipid Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
